secwatch.observer — SEC 8-K summary
======================================

Issuer:     QuidelOrtho Corp (QDEL)
CIK:        0001906324
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0001906324-25-000003
Event type: earnings
Sentiment:  positive
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QuidelOrtho expects Q4 2024 revenue of $702-707M, above guidance midpoint
-------------------------------------------------------------------------

- Preliminary total revenue $702-707M, in line with prior guidance; non-respiratory $561-563M, respiratory $141-143M.
- CEO states 'positive note' and expects top-line above 2024 guidance midpoint; full results due Feb 12, 2025.
- Company highlights cost-savings initiatives and leadership realignment during fiscal 2024.
- Respiratory revenue ranges reflect lower Q4 demand compared to prior year; Labs segment also in line.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1906324/000190632425000003/0001906324-25-000003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1906324/000190632425000003/qdel-20250113.htm
  HTML page:      https://secwatch.observer/filing/0001906324-25-000003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer